Previous studies of our research group have revealed that blockade of EZH2 protects against AKI [33, 48] and EZH2 could sustainably promote the progression of renal fibrosis in CKD mice (renal injury induced by hyperuricemia and UUO) [16, 49, 50]. Here, EZH2 is linked to chronic kidney disease.